I Gonzalez-Munoz, M V Leal Arranz, J A Garcia Fuentes, B Santos Zorrozua, M Zuriarrain Alonso, L Altube Urrengoechea, J Ugedo Urruela, E Tabernero Huguet
{"title":"Non-tuberculous micobacteria in the elderly. Multicentric study.","authors":"I Gonzalez-Munoz, M V Leal Arranz, J A Garcia Fuentes, B Santos Zorrozua, M Zuriarrain Alonso, L Altube Urrengoechea, J Ugedo Urruela, E Tabernero Huguet","doi":"10.1016/j.rmed.2025.108297","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Nontuberculous mycobacterial (NTM) pulmonary disease is an increasingly common infectious condition that particularly affects patients with pre-existing lung disease, immunosuppression, and the elderly.</p><p><strong>Objectives: </strong>To determine the incidence of NTM isolation and NTM pulmonary disease (NTM-PD) in older adults and describe their clinical, radiological characteristics, and treatment outcomes.</p><p><strong>Methods: </strong>A multicenter observational study conducted retrospectively (2012-2017) and prospectively (2018-2020) in five tertiary hospitals in northern Spain. All adults aged ≥18 years with NTM isolation from respiratory samples were included and followed for two years.</p><p><strong>Results: </strong>Among 594 patients, 220 (37 %) were aged >75 years. NTM-PD was confirmed in 192 cases, with 32 % occurring in elderly patients. The isolation rate was higher in older adults (13.8/100,000 vs. 2.94/100,000 in younger individuals), as was the disease rate (3.82/100,000 vs. 1.02/100,000). Older patients had fewer cavitated forms (27 vs 10 %), were less often diagnosed by bronchoscopy, and received proportionally less treatment despite meeting disease criteria. However, cure rates did not significantly differ between age groups.</p><p><strong>Conclusions: </strong>Older adults exhibit a higher incidence of NTM isolation and disease but are managed with less aggressive diagnostic and therapeutic approaches, without compromising cure rates.</p>","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":" ","pages":"108297"},"PeriodicalIF":3.1000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.rmed.2025.108297","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/5 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Nontuberculous mycobacterial (NTM) pulmonary disease is an increasingly common infectious condition that particularly affects patients with pre-existing lung disease, immunosuppression, and the elderly.
Objectives: To determine the incidence of NTM isolation and NTM pulmonary disease (NTM-PD) in older adults and describe their clinical, radiological characteristics, and treatment outcomes.
Methods: A multicenter observational study conducted retrospectively (2012-2017) and prospectively (2018-2020) in five tertiary hospitals in northern Spain. All adults aged ≥18 years with NTM isolation from respiratory samples were included and followed for two years.
Results: Among 594 patients, 220 (37 %) were aged >75 years. NTM-PD was confirmed in 192 cases, with 32 % occurring in elderly patients. The isolation rate was higher in older adults (13.8/100,000 vs. 2.94/100,000 in younger individuals), as was the disease rate (3.82/100,000 vs. 1.02/100,000). Older patients had fewer cavitated forms (27 vs 10 %), were less often diagnosed by bronchoscopy, and received proportionally less treatment despite meeting disease criteria. However, cure rates did not significantly differ between age groups.
Conclusions: Older adults exhibit a higher incidence of NTM isolation and disease but are managed with less aggressive diagnostic and therapeutic approaches, without compromising cure rates.
期刊介绍:
Respiratory Medicine is an internationally-renowned journal devoted to the rapid publication of clinically-relevant respiratory medicine research. It combines cutting-edge original research with state-of-the-art reviews dealing with all aspects of respiratory diseases and therapeutic interventions. Topics include adult and paediatric medicine, epidemiology, immunology and cell biology, physiology, occupational disorders, and the role of allergens and pollutants.
Respiratory Medicine is increasingly the journal of choice for publication of phased trial work, commenting on effectiveness, dosage and methods of action.